GlassScriptPhysician profile
Allyson Renee Black
NPI 1760703730
$1,137.67
in general payments reported to CMS, 2019-2025
26 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $59.26 · 2022: $100 · 2023: $71.42 · 2024: $207 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467 · Education: $47.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.85 |
| Education | $47.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $147.77 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.88 | 2019-2025 | Jardiance |
| Amgen INC. | $118.50 | 2019-2022 | |
| Lilly USA, LLC | $88.23 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $58.62 | 2019-2025 | |
| Ucb, INC. | $51.45 | 2019-2024 | Bimzelx |
| Exact Sciences Corporation | $49.95 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $47.68 | 2019-2025 | |
| Dynavax Technologies Corporation | $47.41 | 2019-2025 | Heplisav-B |
| Kyowa Kirin, INC. | $47.00 | 2023-2024 | Poteligeo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.39 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $39.88 | 2019 | |
| Botanix Sb INC | $28.19 | 2025 | Sofdra |
| Merck Sharp & Dohme LLC | $27.54 | 2022-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Globus Medical, INC. | $25.11 | 2025 | Senza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $22.78 | 2022 | |
| Pfizer INC. | $22.14 | 2019 | |
| Arcutis Biotherapeutics, INC. | $21.20 | 2024 | Zoryve |
| Amarin Pharma, INC. | $20.02 | 2019 | |
| Dexcom, INC. | $19.12 | 2025 | Dexcom G6 Transmitter |
| Genzyme Corporation | $18.62 | 2020 | |
| Novo Nordisk INC | $18.51 | 2024 | Rybelsus, Ozempic |
| Galderma Laboratories, L.P. | $16.13 | 2020 | |
| Inspire Medical Systems, INC. | $14.69 | 2025 | Inspire |
| Vyne Pharmaceuticals INC. | $11.45 | 2020 | |
| Astellas Pharma US INC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.